Cargando…

In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer

Tumor angiogenesis and lymphangiogenesis pathways have been identified as important therapeutic targets in non-small cell lung cancer (NSCLC). Bevacizumab, which is a monoclonal antibody, was the initial inhibitor of angiogenesis and lymphangiogenesis that received approval for use in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lung-Ching, Mokgautsi, Ntlotlang, Kuo, Yu-Cheng, Wu, Alexander T. H., Huang, Hsu-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376976/ https://www.ncbi.nlm.nih.gov/pubmed/37509650 http://dx.doi.org/10.3390/biomedicines11072011

Ejemplares similares

Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects
por: Huang, Tse-Hung, et al.
Publicado: (2021)

Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2023)

Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2023)

Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent
por: Chinyama, Harold A., et al.
Publicado: (2023)

HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses
por: Lee, Jih-Chin, et al.
Publicado: (2020)

Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2022)

In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents
por: Chen, Yi-Fong, et al.
Publicado: (2023)

Angiogenesis and Lymphangiogenesis of Gastric Cancer
por: Kitadai, Yasuhiko
Publicado: (2010)

Angiogenesis, lymphangiogenesis and clinical implications
por: Naik, Sita
Publicado: (2015)

Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
por: Penco-Campillo, Manon, et al.
Publicado: (2023)

Lymphangiogenesis and Angiogenesis in Abdominal Aortic Aneurysm
por: Sano, Masaki, et al.
Publicado: (2014)

The role of lymphangiogenesis and angiogenesis in tumor metastasis
por: Paduch, Roman
Publicado: (2016)

The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors
por: Wasik, Adrian, et al.
Publicado: (2022)

In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1
por: Khedkar, Harshita Nivrutti, et al.
Publicado: (2021)

Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis
por: Lin, Shian-Ren, et al.
Publicado: (2020)

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
por: Lawal, Bashir, et al.
Publicado: (2021)

Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
por: Hwang, Ilseon, et al.
Publicado: (2020)

Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
por: Boneberg, E-M, et al.
Publicado: (2009)

High Throughput FISH Screening Identifies Small Molecules That Modulate Oncogenic lncRNA MALAT1 via GSK3B and hnRNPs
por: Zablowsky, Nina, et al.
Publicado: (2023)

Angiogenesis and Lymphangiogenesis in the Spectrum of Leprosy and Its Reactional Forms
por: Soares, Cleverson Teixeira, et al.
Publicado: (2013)

Lymphangiogenesis and angiogenesis during human fetal pancreas development
por: Roost, Matthias S, et al.
Publicado: (2014)

Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
por: Riabov, Vladimir, et al.
Publicado: (2014)

Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
por: Sammarco, Giuseppe, et al.
Publicado: (2019)

Increased Angiogenesis and Lymphangiogenesis in Adenomyosis Visualized by Multiplex Immunohistochemistry
por: Harmsen, Marissa J., et al.
Publicado: (2022)

Small molecule inhibitors of RAS proteins with oncogenic mutations
por: Orgován, Zoltán, et al.
Publicado: (2020)

In Vitro, In Vivo, and In Silico Models of Lymphangiogenesis in Solid Malignancies
por: Bekisz, Sophie, et al.
Publicado: (2022)

Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines
por: Lawal, Bashir, et al.
Publicado: (2021)

An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2021)

Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2021)

All-Small-Molecule Organic Solar Cells Based on a Fluorinated Small Molecule Donor With High Open-Circuit Voltage of 1.07 V
por: Liu, Chunyan, et al.
Publicado: (2020)

M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
por: Kubota, Yoshiaki, et al.
Publicado: (2009)

PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis
por: Nassar, Zeyad D., et al.
Publicado: (2013)

Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy
por: Jones, Dennis
Publicado: (2020)

Characterization of the sex-specific pattern of angiogenesis and lymphangiogenesis in aortic stenosis
por: Matilla, Lara, et al.
Publicado: (2022)

Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis
por: Liu, Xiaoxin, et al.
Publicado: (2023)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
por: Moccia, Marialuisa, et al.
Publicado: (2015)

Prospective Development of Small Molecule Targets to Oncogenic Ras Proteins
por: Chandrashekar, Reena, et al.
Publicado: (2013)

A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling
por: Wu, Alexander T. H., et al.
Publicado: (2021)

Defining RNA–Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA
por: Velagapudi, Sai Pradeep, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v9gits561oo7c8v5q4vdepg6dj